Over 200,000 sign petitions urging UK government to end Palantir contracts
Public and political pressure is mounting over the US tech firm’s role in NHS and other UK public services, though the government has not signalled an immediate exit
A UK public procurement framework that allows private technology companies to run large-scale government data systems is at the centre of renewed political and public pressure, as more than 200,000 people call on ministers to end contracts with US software company Palantir Technologies.
The story is system-driven: it concerns how the UK government uses external technology providers to manage sensitive public-sector data, including healthcare records, policing information, and defence logistics, rather than a single isolated contract dispute.
The petitions, which together have attracted more than 229,000 signatures, demand the cancellation of Palantir’s agreements with the UK government, most prominently its £330 million contract with NHS England to build and operate the Federated Data Platform, a system designed to connect fragmented hospital data and improve operational efficiency.
What is confirmed is that Palantir holds multiple major UK public-sector contracts worth several hundred million pounds, including work across the National Health Service, the Ministry of Defence, and other agencies.
The NHS contract was awarded in 2023 and runs for seven years, with a break clause allowing reconsideration in 2027.
Opposition to the company has intensified across campaign groups, medical organisations, and sections of Parliament.
Critics argue that Palantir’s past work with US government agencies, including immigration enforcement, and its associations with military and intelligence projects raise ethical concerns about entrusting it with sensitive public data.
Some also question whether sufficient transparency exists around how the NHS platform is procured and operated.
Government officials have not announced plans to terminate the contract immediately, but they have acknowledged scrutiny of its terms, including the possibility of exercising the break clause if alternatives emerge.
Internal parliamentary debate has reflected both concerns about trust and arguments that the system is already delivering operational improvements in parts of the NHS.
What remains unclear is whether political pressure will translate into a policy shift.
While campaigners and some MPs are urging a full withdrawal from Palantir’s systems, others argue that replacing the technology at scale would be complex and potentially disruptive to NHS operations already reliant on the platform.
Palantir itself has defended its role, stating that its systems are designed to integrate existing NHS data infrastructure to reduce waiting times and improve resource allocation, and it maintains that it does not access or use patient data for commercial purposes.
Those assurances have not resolved wider concerns about long-term data governance and foreign involvement in critical national infrastructure.
The debate now sits between competing pressures: public distrust of a powerful foreign technology contractor on one side, and the operational dependence of parts of the UK public sector on its systems on the other.
The story is system-driven: it concerns how the UK government uses external technology providers to manage sensitive public-sector data, including healthcare records, policing information, and defence logistics, rather than a single isolated contract dispute.
The petitions, which together have attracted more than 229,000 signatures, demand the cancellation of Palantir’s agreements with the UK government, most prominently its £330 million contract with NHS England to build and operate the Federated Data Platform, a system designed to connect fragmented hospital data and improve operational efficiency.
What is confirmed is that Palantir holds multiple major UK public-sector contracts worth several hundred million pounds, including work across the National Health Service, the Ministry of Defence, and other agencies.
The NHS contract was awarded in 2023 and runs for seven years, with a break clause allowing reconsideration in 2027.
Opposition to the company has intensified across campaign groups, medical organisations, and sections of Parliament.
Critics argue that Palantir’s past work with US government agencies, including immigration enforcement, and its associations with military and intelligence projects raise ethical concerns about entrusting it with sensitive public data.
Some also question whether sufficient transparency exists around how the NHS platform is procured and operated.
Government officials have not announced plans to terminate the contract immediately, but they have acknowledged scrutiny of its terms, including the possibility of exercising the break clause if alternatives emerge.
Internal parliamentary debate has reflected both concerns about trust and arguments that the system is already delivering operational improvements in parts of the NHS.
What remains unclear is whether political pressure will translate into a policy shift.
While campaigners and some MPs are urging a full withdrawal from Palantir’s systems, others argue that replacing the technology at scale would be complex and potentially disruptive to NHS operations already reliant on the platform.
Palantir itself has defended its role, stating that its systems are designed to integrate existing NHS data infrastructure to reduce waiting times and improve resource allocation, and it maintains that it does not access or use patient data for commercial purposes.
Those assurances have not resolved wider concerns about long-term data governance and foreign involvement in critical national infrastructure.
The debate now sits between competing pressures: public distrust of a powerful foreign technology contractor on one side, and the operational dependence of parts of the UK public sector on its systems on the other.
